AST-002

N/A

Report date: 2022/12/28 13:51:31
NME

Base Information

Drug NameAST-002
Drug Alias NameAST-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsSmall Cell Lung CarcinomaBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAscentawits Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAscentawits Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsSmall Cell Lung CarcinomaBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A